The pharmaceutical industry is fighting a losing battle: it

The pharmaceutical industry is fighting a losing battle: it simply does not have the resources to prosecute all of the generic companies which illegally copy the patented molecules. Because the number of companies which will be charged with a crime is so limited, the actions of the pharmaceutical industry will have a minimal impact on the number of companies which illegally copy patented molecules.

The answer to which of the following questions would best help evaluate the accuracy of the conclusion above?

A) Will pharmaceutical industry lawyers dedicate the majority of their time to prosecuting companies which illegally copy patented molecules?

B) Is a small minority of companies responsible for the majority of illegal copying of molecules?

C) Do many companies which illegally copy the patented molecules share their products with other companies?

D) Will new dedicated enforcement agency permit the pharmaceutical industry to more quickly and easily identify companies who illegally copy patented molecules?

E) Will the threat of prosecution alter the behaviour of those companies which illegally copy patented molecules?